These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19422401)

  • 1. The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies.
    Strachan MW; Reynolds RM; Frier BM; Mitchell RJ; Price JF
    Diabetes Obes Metab; 2009 May; 11(5):407-14. PubMed ID: 19422401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
    Góth M; Hubina E; Korbonits M
    Orv Hetil; 2005 Jan; 146(2):51-5. PubMed ID: 15724952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between type 2 diabetes and dementia.
    Strachan MW; Reynolds RM; Frier BM; Mitchell RJ; Price JF
    Br Med Bull; 2008; 88(1):131-46. PubMed ID: 19029150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the role of cortisol and metabolic syndrome in age-related degenerative diseases.
    Martocchia A; Stefanelli M; Falaschi GM; Toussan L; Ferri C; Falaschi P
    Aging Clin Exp Res; 2016 Feb; 28(1):17-23. PubMed ID: 25813987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome.
    Wang M
    Curr Opin Investig Drugs; 2006 Apr; 7(4):319-23. PubMed ID: 16625818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
    Walker BR; Andrew R
    Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders.
    Martocchia A; Curto M; Toussan L; Stefanelli M; Falaschi P
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):196-204. PubMed ID: 21834781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia.
    Strachan MW
    Diabet Med; 2011 Feb; 28(2):141-7. PubMed ID: 21219420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus.
    Bruehl H; Wolf OT; Sweat V; Tirsi A; Richardson S; Convit A
    Brain Res; 2009 Jul; 1280():186-94. PubMed ID: 19463794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive function, dementia and type 2 diabetes mellitus in the elderly.
    Strachan MW; Reynolds RM; Marioni RE; Price JF
    Nat Rev Endocrinol; 2011 Feb; 7(2):108-14. PubMed ID: 21263438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus.
    Joseph JJ; Golden SH
    Ann N Y Acad Sci; 2017 Mar; 1391(1):20-34. PubMed ID: 27750377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
    Malouf R; Grimley Evans J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004514. PubMed ID: 18843658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke.
    Rosmond R; Björntorp P
    J Intern Med; 2000 Feb; 247(2):188-97. PubMed ID: 10692081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia.
    Areosa SA; Grimley EV
    Cochrane Database Syst Rev; 2002; (4):CD003804. PubMed ID: 12519608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes.
    Bruehl H; Rueger M; Dziobek I; Sweat V; Tirsi A; Javier E; Arentoft A; Wolf OT; Convit A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2439-45. PubMed ID: 17426095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.